REFERENCES
- American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes care. 2003; 26: 917–32.
- The World Bank World Development Report 1993. Investing in Health. Oxford, England: Oxford University Press, 1993.
- Norlund A, Apelqvist J, Bitzen PO, et al. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med. 2001; 250: 57–65.
- Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, et al. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health. 2004; 14: 3–9.
- Amos AF, Mc Carty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 1997;14(suppl 5):S1-S85.
- Fleming DM, Schellevis FG, Van Casteren V. The prevalence of known diabetes in eight European countries. Eur J Public Health. 2004; 14: 10–4.
- Skerjanc A. Sickness absence in diabetic employees. Occup Environment Med. 2001; 58: 432–6.
- Griffiths RD, Moses RG. Diabetes in the workplace. Employment experiences of young people with diabetes mellitus. Med J Aust 1993; 158: 169–71.
- Welch RA. Employment of diabetics in a post office region. J Soc Occup Med. 1986; 36: 80–5.
- Moore RH, Bushbom RL. Work absenteeism in diabetics. Diabetes. 1974; 23: 957–61.
- Waclawski ER. Sickness absence among insulin treated diabetic employees. Diabetic Med. 1990; 7: 41–4.
- Poole CSM, Gibbons D, Cawert IA. Sickness absence in diabetic employees at a large engineering factory. Occup Environment Med. 1994; 51: 299–301.
- Baker J, Scragg R, Metcalf P, et al. Diabetes mellitus and employment: is there discrimination in the workplace? Diabetic Med. 1993; 10: 362–65.
- Lister J. The employment of diabetics. Br Med J. 1983; 287: 1087–8.
- Robinson N, Bush L, Protopapa LE, et al. Employers' attitudes to diabetes. Diabetic Med. 1989; 6: 692–7.
- Coetsier P, De Backer G, De Corte W, et al. Etude belge du stress au travail: aspects du modele de recherche et des outils d'investigation [Belgian Job Stress Study: overview of the study model and research methods]. Revue de Psychologie et de Psychometric. 1996; 17: 17–35. [In French]
- Pelfrene E. Job stress and health: cross-sectional findings from the Belstress study. PhD thesis, Ghent University, Ghent, Belgium, 2003. ISBN 90-806261-2-0.
- NEVO Table, Nederlands voedingsstoffenbestand [Dutch Food Composition Tabel] Zeist, The Netherlands: NEVO, 2001.
- Mastekaasa A. Parenthood, gender and sickness absence. Soc Sci Med. 2000; 50: 1827–42.
- Marmot M, Feeney A, Shipley M, et al. Sickness absence as a measure of health status and functioning: from the Whitehall II study. J Epidemiol Commun Health. 1995; 49: 124–30.
- Mexanderson K, Leijon M, Akorlind I, et at Epidemiology of sickness absence in a Swedish county in 1985, 1986 and 1987. Scand J Soc Med. 1994; 22: 27–34.
- The SAS system: Release 6.12, Cary, NC: SAS Institute, Inc.
- Larsson D, Lager I, Nilsson PM. Socio-economic characteristics and quality of life in diabetes mellitus-relation to metabolic control. Scand J Public Health. 1999; 2: 101–5.
- Pyörd. B. K, Lehto S, De Bacquer D, et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings form the EUROASPIRE I and II surveys. Diabetologia. 2004; 47: 1257-65.
- Benavides F, Benach J, Mira M, et al. Occupational categories and sickness absence certified as attributable to common diseases. Eur J Public Health. 2003; 13: 51–5.
- Moreau M, Valente F, Mal R, et al Obesity, body fat distribution and incidence of sick leave in the Belgian workforce: the Belstress study. Int J Obesity. 2004;28,:574–82.
- Pell S, d'Alonzo CA. Sickness absence in employed diabetics. Am J Public Health. 1976; 57: 253–60.
- Haynes RB, Sackett DL, Taylor DW, et al. Increased absenteeism from work after detection and labelling of hypertensive patients. N Engl J Med. 1978; 299: 741–4
- Charlson M, Alderman M, Melcher L. Absenteeism and labelling in hypertensive subjects. Am J Med. 1982; 73: 165–70.
- Polk BF, Harlan LC, Cooper SP, et al. Disability days associated with detection and treatment in a hypertensive control program. Am J Epidemiol. 1984; 119: 4453.
- Rastan L, Frick JO, Gulberg B. Work absenteeism in men who are labelled hypercholesterolaemic at screening. Eur Heart J. 1991; 12: 1316–20.
- Leynen F, De Backer G, Pelfrene E, et al. Increased absenteeism from work among aware and treated hypertensives/hypercho-lesterolaemics. Eur J Cardiovasc Prey Rehabil. In press.